NCT05842876

Brief Summary

The goal of this observational study is to determine the feasibility of renal Near Infrared Spectroscopy (NIRS) monitoring in the newborn nursery for newborns at low risk of coarctation of the aorta (CoA). The main questions it aims to answer are:

  • whether continuous renal NIRS monitoring is feasible;
  • whether NIRS monitoring results in higher nursing and parent/caregiver satisfaction than current standard monitoring; and,
  • whether participants who develop CoA will spend a smaller proportion of time within the normal range than patients who do not have CoA. Participants will be observed through continuous renal oxygenation monitoring with NIRS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 19, 2023

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

April 21, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

May 6, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 21, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 21, 2025

Completed
Last Updated

March 10, 2025

Status Verified

March 1, 2025

Enrollment Period

1.8 years

First QC Date

April 21, 2023

Last Update Submit

March 7, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Percent of time monitored

    Amount of time continuously monitored will be calculated

    Up to 2 weeks post-delivery, on average

  • Count of adverse and unexpected events

    All adverse and unexpected events will be recorded

    Up to 2 weeks post-delivery

Secondary Outcomes (3)

  • Change in nursing satisfaction with renal NIRS monitoring

    Study start to one year later

  • Parent/caregiver satisfaction with renal NIRS monitoring

    Up to 2 weeks post-delivery, on average

  • Renal oxygen trends

    Through study completion, approximately 1 year

Study Arms (3)

Caregiver + Low Risk neonates

Participants in the nursery who are expected to be lower risk for CoA

Device: Continuous Renal NIRS MonitoringDiagnostic Test: Standard Clinical CareOther: Satisfaction Survey

Caregiver + Medium to High Risk neonates

Participants in the NICU who are expected to be at a higher risk for CoA

Diagnostic Test: Standard Clinical Care

Nurses in the Newborn Nursery

Nurses who work at the Meriter Hospital, Inc. Newborn Nursery

Other: Satisfaction Survey

Interventions

Renal oxygenation data collected every 6 seconds

Caregiver + Low Risk neonates
Standard Clinical CareDIAGNOSTIC_TEST

q6 h BP, q6 h Pulse ox, Echo at 24-72h

Caregiver + Low Risk neonates

Survey to assess which method of monitoring is preferred

Caregiver + Low Risk neonatesNurses in the Newborn Nursery

Eligibility Criteria

Age15 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

1. Neonates admitted to the nursery or NICU at Meriter Hospital, Inc. or UWHealth Kids - American Family Children's Hospital (AFCH) who are ≥ 35 weeks' gestation and have a prenatally identified concern for coarctation of the aorta. 2. Primary parent/guardian of neonate. 3. Nursing staff at Meriter Hospital, Inc.'s Newborn Nursery

You may qualify if:

  • Delivered at ≥ 35 weeks of gestation
  • \<12 hours of age
  • Inpatient at Meriter Hospital, Inc. NICU or Newborn Nursery or AFCH PICU or NICU
  • Diagnosed as at risk for CoA

You may not qualify if:

  • Major congenital anomalies of the kidney
  • Attending physician's discretion to not place sensors due to clinical concerns
  • In the researcher's medical opinion, there is a significant likelihood that the neonate would not survive the first 3 days of life
  • Able to understand and the willing to sign a written informed consent document
  • Willing to comply with all study procedures and be available for the duration of the study
  • Birth parent (i.e., the parent who gave birth to the baby) who is the primary caregiver of a neonate who is eligible to participate in study
  • Agrees to enroll neonate into study
  • Aged 15 years or older
  • Pregnant mother with a baby diagnosed prenatally as at risk for CoA will be eligible for the study. They must also meet the following criteria:
  • Require an "arch watch care plan" as a results of prenatal ultrasonography findings
  • Agree to enroll offspring into the study at birth
  • Subject is unable to provide informed consent, including subjects who are in foster care and subjects within state custody
  • Pregnant woman who does not plan to maintain custody of the child after birth, such as instances of adoption or surrogacy
  • Newborn Nursery Nursing Staff:
  • All Newborn Nursery nursing staff at Meriter Hospital, Inc.'s Newborn Nursery are eligible to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Wisconsin

Madison, Wisconsin, 53705, United States

Location

Meriter Hospital, Inc.

Madison, Wisconsin, 53715, United States

Location

Related Publications (6)

  • Singh Y. Evaluation of a child with suspected congenital heart disease. Paediatrics and Child Health 2018, 28(12): 556-561

    BACKGROUND
  • Levey A, Glickstein JS, Kleinman CS, Levasseur SM, Chen J, Gersony WM, Williams IA. The impact of prenatal diagnosis of complex congenital heart disease on neonatal outcomes. Pediatr Cardiol. 2010 Jul;31(5):587-97. doi: 10.1007/s00246-010-9648-2. Epub 2010 Feb 18.

    PMID: 20165844BACKGROUND
  • Gomez-Montes E, Herraiz Garcia I, Escribano Abad D, Rodriguez Calvo J, Villalain Gonzalez C, Galindo Izquierdo A. Application of a Global Multiparameter Scoring System for the Prenatal Prediction of Coarctation of the Aorta. J Clin Med. 2021 Aug 20;10(16):3690. doi: 10.3390/jcm10163690.

    PMID: 34441986BACKGROUND
  • Maskatia SA, Kwiatkowski D, Bhombal S, Davis AS, McElhinney DB, Tacy TA, Algaze C, Blumenfeld Y, Quirin A, Punn R. A Fetal Risk Stratification Pathway for Neonatal Aortic Coarctation Reduces Medical Exposure. J Pediatr. 2021 Oct;237:102-108.e3. doi: 10.1016/j.jpeds.2021.06.047. Epub 2021 Jun 26.

    PMID: 34181988BACKGROUND
  • Korcek P, Stranak Z, Sirc J, Naulaers G. The role of near-infrared spectroscopy monitoring in preterm infants. J Perinatol. 2017 Oct;37(10):1070-1077. doi: 10.1038/jp.2017.60. Epub 2017 May 4.

    PMID: 28471443BACKGROUND
  • Hazle MA, Gajarski RJ, Aiyagari R, Yu S, Abraham A, Donohue J, Blatt NB. Urinary biomarkers and renal near-infrared spectroscopy predict intensive care unit outcomes after cardiac surgery in infants younger than 6 months of age. J Thorac Cardiovasc Surg. 2013 Oct;146(4):861-867.e1. doi: 10.1016/j.jtcvs.2012.12.012. Epub 2013 Jan 12.

    PMID: 23317940BACKGROUND

MeSH Terms

Conditions

Aortic Coarctation

Condition Hierarchy (Ancestors)

Heart Defects, CongenitalCardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Matthew Harer, MD

    University of Wisconsin, Madison

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 21, 2023

First Posted

May 6, 2023

Study Start

April 19, 2023

Primary Completion

January 21, 2025

Study Completion

January 21, 2025

Last Updated

March 10, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations